NL-OMON42941已完成不适用
A multi-centre, comparative, double blind, randomised cross-over trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from the pivotal process and turoctocog alfa pegol from the commercial process in patients with severe haemophilia A - pathfinder*7
ovo Nordisk0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial.;2. Ongoing participation in pathfinder*2 (NN7088-3859);3. Male, age * 12 years at the time of signing informed consent (in certain countries the lower age limit will be 18 years, according to local requirements)
排除标准
- •1. FVIII inhibitors (*0.6 BU) at last visit in pathfinder*2 prior to entry in pathfinder*7;2. Planned surgery during the trial;3. Major surgery performed within 4 weeks prior to screening;4. Previous participation in this trial. Participation is defined as signed informed consent;5. Any disorder, except for conditions associated with haemophilia A, which in the investigator*s opinion might jeopardise patient*s safety or compliance with the protocol
研究者
相似试验
进行中（未招募）
1 期
A trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from two different production processes in patients with severe haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2015-005327-63-NLovo Nordisk A/S21
进行中（未招募）
1 期
A trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from two different production processes in patients with severe haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2015-005327-63-DKovo Nordisk A/S22
进行中（未招募）
1 期
A trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from two different production processes in patients with severe haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2015-005327-63-FRovo Nordisk A/S22
进行中（未招募）
1 期
A trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from two different production processes in patients with severe haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2015-005327-63-ESovo Nordisk A/S22
进行中（未招募）
1 期
A trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from two different production processes in patients with severe haemophilia AHaemophilia AMedDRA version: 20.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2015-005327-63-DEovo Nordisk A/S22